What We're Reading: Page 43
Industry reads hand-picked by our editors
Jun 27, 2024
-
AP News
The Supreme Court rejects a nationwide opioid settlement with OxyContin maker Purdue Pharma
-
Reuters
US FDA approves Verona Pharma’s inhaled COPD therapy
-
Hunterbrook Media
Hims & Hers Selling GLP-1 Injection That’s Not FDA Approved, From Shady Supplier — And Won’t Make You Talk to a Doctor to Get It
Jun 26, 2024
Jun 25, 2024
-
Financial Times
Novo Nordisk weight loss drug Wegovy approved in China
-
BioCentury
FDA’s different Peter principle problem: poorly articulated, idiosyncratic decision-making
-
Bloomberg
A Brain Cancer Treatment for Kids Started with Family Fundraisers
-
MIT Technology Review
Is this the end of animal testing?
Jun 24, 2024
-
AP News
Gene therapy may cure rare diseases. But drugmakers have few incentives, leaving families desperate
-
PMLive
Bristol Myers Squibb’s Krazati granted FDA accelerated approval in colorectal cancer
-
C&EN
Macrocyclic peptides: Aiming for the perfect fit
-
Axios
How the health system is trying to improve postpartum care
Jun 21, 2024
-
The New York Times
How PBMs Are Driving Up Prescription Drug Costs
-
Bloomberg
Vertex Reaches Pricing Deal With NHS for Cystic Fibrosis Drugs
-
FirstWord Pharma
FDA proposes easier path for biosimilars to obtain interchangeability
-
Nature
Gut microbiome discovery provides roadmap for life-saving cancer therapies
Jun 20, 2024
-
The Washington Post
Rare gene mutation helps people resist Alzheimer’s disease
-
ApexOnco
Merck seeks the next Keytruda
-
Reuters
Lilly files more lawsuits to curb sales of counterfeit Mounjaro
Previous
